Clinical trial
Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to…
NCT00121147 · Hermann Eye Center, Other · Completed
Key facts
| NCT number | NCT00121147 |
|---|---|
| Title | Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan |
| Official title | A Comparison of the Additivity of Brinzolamide Ophthalmic Suspension, 1% (Azopt) and Brimonidine Tartrate Ophthalmic Solution, 0.15% (Alphagan P) to Travoprost Ophthalmic Solution, 0.004% (Travatan) in Patients With Elevated IOP on Travoprost. A Three Month Double-Masked, Multi-Center Trial in the… |
| Lead sponsor | Hermann Eye Center, Other |
| Collaborators | Alcon Research Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Open Angle Glaucoma, Ocular Hypertension, Pseudoexfoliation Syndrome |
| Intervention type | Drug |
| Interventions | Travatan, Azopt, Alphagan P |
| Enrollment | 200 |
| Start date | Sep 1, 2003 |
| Completion | Oct 1, 2005 |
| First posted | Jul 21, 2005 |
| Last update posted | Feb 24, 2006 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: